Sponsor or institution
Clinical trials and research at Celltrion
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Celltrion that are recruiting, at sites in 2 countries (most in South Korea (1), Poland (1)). By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Adding empagliflozin to alogliptin and metformin for type 2 diabetes
This study tests whether adding empagliflozin to adults already taking alogliptin and metformin improves blood sugar control and is safe for people with type 2 diabetes who still have high blood sugar.
-
Comparing CT-P53 and Ocrevus for treating relapsing-remitting multiple sclerosis
This study is testing if a new treatment called CT-P53 works as well and is as safe as Ocrevus for people with relapsing-remitting multiple sclerosis.
Quick answers
How many clinical trials run by Celltrion are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in South Korea (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.